473 related articles for article (PubMed ID: 30662405)
81. Liver-specific deletion of 3-hydroxy-3-methylglutaryl coenzyme A reductase causes hepatic steatosis and death.
Nagashima S; Yagyu H; Ohashi K; Tazoe F; Takahashi M; Ohshiro T; Bayasgalan T; Okada K; Sekiya M; Osuga J; Ishibashi S
Arterioscler Thromb Vasc Biol; 2012 Aug; 32(8):1824-31. PubMed ID: 22701022
[TBL] [Abstract][Full Text] [Related]
82. The 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) pathway regulates developmental cerebral-vascular stability via prenylation-dependent signalling pathway.
Eisa-Beygi S; Hatch G; Noble S; Ekker M; Moon TW
Dev Biol; 2013 Jan; 373(2):258-66. PubMed ID: 23206891
[TBL] [Abstract][Full Text] [Related]
83. Key roles of Rho GTPases, YAP, and Mutant P53 in anti-neoplastic effects of statins.
Ji L; Liu C; Yuan Y; Gao H; Tang ZX; Yang Z; Liu ZT; Jiang GH
Fundam Clin Pharmacol; 2020 Feb; 34(1):4-10. PubMed ID: 31241783
[TBL] [Abstract][Full Text] [Related]
84. Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes.
Krysiak R; Okopień B; Herman Z
Drugs; 2003; 63(17):1821-54. PubMed ID: 12921488
[TBL] [Abstract][Full Text] [Related]
85. Statins induce apoptosis through inhibition of Ras signaling pathways and enhancement of Bim and p27 expression in human hematopoietic tumor cells.
Fujiwara D; Tsubaki M; Takeda T; Tomonari Y; Koumoto YI; Sakaguchi K; Nishida S
Tumour Biol; 2017 Oct; 39(10):1010428317734947. PubMed ID: 28990465
[TBL] [Abstract][Full Text] [Related]
86. Cell cycle arrest by the isoprenoids perillyl alcohol, geraniol, and farnesol is mediated by p21(Cip1) and p27(Kip1) in human pancreatic adenocarcinoma cells.
Wiseman DA; Werner SR; Crowell PL
J Pharmacol Exp Ther; 2007 Mar; 320(3):1163-70. PubMed ID: 17138864
[TBL] [Abstract][Full Text] [Related]
87. Resveratrol inhibits the mevalonate pathway and potentiates the antiproliferative effects of simvastatin in rat theca-interstitial cells.
Wong DH; Villanueva JA; Cress AB; Sokalska A; Ortega I; Duleba AJ
Fertil Steril; 2011 Nov; 96(5):1252-8. PubMed ID: 21907337
[TBL] [Abstract][Full Text] [Related]
88. The Statin Target HMG-Coenzyme a Reductase (Hmgcr) Regulates Sleep Homeostasis in
Alsehli AM; Liao S; Al-Sabri MH; Vasionis L; Purohit A; Behare N; Clemensson LE; Williams MJ; Schiöth HB
Pharmaceuticals (Basel); 2022 Jan; 15(1):. PubMed ID: 35056136
[TBL] [Abstract][Full Text] [Related]
89. Stromal regulation of prostate cancer cell growth by mevalonate pathway enzymes HMGCS1 and HMGCR.
Ashida S; Kawada C; Inoue K
Oncol Lett; 2017 Dec; 14(6):6533-6542. PubMed ID: 29163687
[TBL] [Abstract][Full Text] [Related]
90. Statin as a therapeutic agent in gastroenterological cancer.
Uemura N; Hayashi H; Baba H
World J Gastrointest Oncol; 2022 Jan; 14(1):110-123. PubMed ID: 35116106
[TBL] [Abstract][Full Text] [Related]
91. Synergistic Impact of Xanthorrhizol and
Chan D; Meister ML; Madhani CR; Elfakhani M; Yount ST; Ji X; Feresin RG; Wanders D; Mo H
Nutr Cancer; 2021; 73(9):1746-1757. PubMed ID: 32811212
[TBL] [Abstract][Full Text] [Related]
92. Concomitant attenuation of HMG-CoA reductase expression potentiates the cancer cell growth-inhibitory effect of statins and expands their efficacy in tumor cells with epithelial characteristics.
Ishikawa T; Hosaka YZ; Beckwitt C; Wells A; Oltvai ZN; Warita K
Oncotarget; 2018 Jun; 9(50):29304-29315. PubMed ID: 30034619
[TBL] [Abstract][Full Text] [Related]
93. Statins as anti-tumor agents: A paradigm for repurposed drugs.
Tripathi S; Gupta E; Galande S
Cancer Rep (Hoboken); 2024 May; 7(5):e2078. PubMed ID: 38711272
[TBL] [Abstract][Full Text] [Related]
94. Role of the Mevalonate Pathway in Adrenocortical Tumorigenesis.
Lima-Valassi HP; Lerario AM; Montenegro LR; Fragoso MCBV; Almeida MQ; Mendonca BB; Lin CJ
Horm Metab Res; 2021 Feb; 53(2):124-131. PubMed ID: 33307558
[TBL] [Abstract][Full Text] [Related]
95. Statin use, HMGCR expression, and breast cancer survival - The Malmö Diet and Cancer Study.
Bjarnadottir O; Feldt M; Inasu M; Bendahl PO; Elebro K; Kimbung S; Borgquist S
Sci Rep; 2020 Jan; 10(1):558. PubMed ID: 31953433
[TBL] [Abstract][Full Text] [Related]
96. Mevalonate biosynthesis pathway regulates the development and survival of brown adipocytes.
Kwon J; Yeh YS; Kawarasaki S; Minamino H; Fujita Y; Okamatsu-Ogura Y; Takahashi H; Nomura W; Matsumura S; Yu R; Kimura K; Saito M; Inagaki N; Inoue K; Kawada T; Goto T
iScience; 2023 Mar; 26(3):106161. PubMed ID: 36895651
[TBL] [Abstract][Full Text] [Related]
97. Regulatory effects of statins on Akt signaling for prevention of cancers.
Hosseini FS; Ahmadi A; Kesharwani P; Hosseini H; Sahebkar A
Cell Signal; 2024 Aug; 120():111213. PubMed ID: 38729324
[TBL] [Abstract][Full Text] [Related]
98. Role of hydroxymethylglutharyl-coenzyme A reductase in the induction of stem-like states in breast cancer.
Marks MP; Giménez CA; Isaja L; Vera MB; Borzone FR; Pereyra-Bonnet F; Romorini L; Videla-Richardson GA; Chasseing NA; Calvo JC; Vellón L
J Cancer Res Clin Oncol; 2024 Feb; 150(2):106. PubMed ID: 38418798
[TBL] [Abstract][Full Text] [Related]
99. Importance of Mevalonate Pathway Lipids on the Growth and Survival of Primary and Metastatic Gastric Carcinoma Cells.
Ortiz N; Delgado-Carazo JC; Díaz C
Clin Exp Gastroenterol; 2021; 14():217-228. PubMed ID: 34103960
[TBL] [Abstract][Full Text] [Related]
100. Statins and endocrine resistance in breast cancer.
Hyder T; Marti JLG; Nasrazadani A; Brufsky AM
Cancer Drug Resist; 2021; 4(2):356-364. PubMed ID: 35582035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
